Evidence map›Paper›PMID 23557025›Full record

Trial reportInternational wound journal2015

Doxycycline speeds up healing of chronic venous ulcers.

Raffaele Serra, Luca Gallelli, Gianluca Buffone, Vincenzo Molinari, Domenico M Stillitano, Camillo Palmieri, Stefano de Franciscis

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International wound journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02558426 (Molecular Analysis of Estrogen Receptors in Patients With Chronic Venous Disease), which is not on this map. Cited by 46 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 5 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02558426 completednot on this map

Molecular Analysis of Estrogen Receptors in Patients With Chronic Venous Disease

TypeobservationalSponsorUniversity of CatanzaroRan2015 to 2015Enrolled40ConditionsEstrogen Excess, Varicose VeinsArmsVenous Surgery
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 5 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Cytokines and Venous Leg Ulcer Healing-A Systematic Review.International journal of molecular sciences · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Aterofisiol(®) in carotid plaque evolution.Drug design, development and therapy · 2015
    Trial
  12. Trial
  13. Article
  14. Article
  15. Review
  16. Review
  17. Molecular Determinants of Chronic Venous Disease: A Comprehensive Review.International journal of molecular sciences · 2023
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Raffaele SerraDepartment of Medical and Surgical Science, University Magna Graecia of Catanzaro, Catanzaro, Italy; Interuniversity Center of Phlebolymphology, International Research and Educational Program in Clinical and Experimental Biotechnology, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Luca Gallelli
Gianluca Buffone
Vincenzo Molinari
Domenico M Stillitano
Camillo Palmieri
Stefano de Franciscis
Magna Graecia University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Venous ulcers are common, with an overall prevalence of up to 2% in the general population of western countries, and have significant socioeconomic impact. Matrix metalloproteinases (MMPs) are involved in the alteration of extracellular matrix that could lead to venous ulceration. Sixty-four patients with venous ulcers were recruited in a 22-month period. All patients were subjected to the most appropriate treatment considering also the patient's wishes (compression therapy followed or not by vein surgery). Patients were randomised into two groups of 32 persons in each (groups A and B). Patients of group A in addition to the basic treatment, described above, received the administration of oral low doses of doxycycline 20 mg b.i.d. for 3 months, whereas patients of group B received basic treatment only. Healing was assessed by means of direct ulcer tracing with computerised planimetry. Group A showed a higher healing rate compared with group B. In group B, the lower healing rate was related to higher levels of MMP-9; neutrophil gelatinase-associated lipocalin and vascular endothelial growth factor, documented in plasma; wound fluid and biopsies executed and compared between both groups. Pharmacological treatments, as doxycycline administration, which by means of its immunomodulatory and anti-inflammatory actions, through the inhibition of MMP, could improve extracellular matrix functioning and represent a possible solution to support wound healing.

Indexed as

Acute-Phase ProteinsAdultAnti-Bacterial AgentsChronic DiseaseDoxycyclineFemaleHumansLipocalin-2LipocalinsMaleMatrix Metalloproteinase 9Middle AgedProto-Oncogene ProteinsTreatment OutcomeVaricose UlcerVascular Endothelial Growth Factor AAcute-Phase ProteinsAnti-Bacterial AgentsDoxycyclineLCN2 protein, humanLipocalin-2LipocalinsMatrix Metalloproteinase 9Proto-Oncogene ProteinsVascular Endothelial Growth Factor AChronic venous leg ulcersDoxycyclineMetalloproteinase-9Neutrophil gelatinase-associated lipocalinWound healing

Identifiers

PMID23557025
PMCPMC7950394
OpenAlexW1588253900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.